URGENT PANDEMIC INFORMATION

In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List


2nd Proteome- Targeted Drug Discovery Summit


Date
Nov 16, 2021 - 08:30 AM - Nov 17, 08:30 AM
Organizer
Hanson Wade
Venue
The Westin Boston Waterfront
Location
425 Summer Street,

Boston,
Massachusetts,
United States,
ZIP: 02210
Phone: (+1) 617 455 4188

Ticket Price: Prices: Earlybird Registration: Conference + Workshop: USD 2748.00, Earlybird Registration: Conference Only: USD 2299.00, Standard Rate: Conference + Workshop: USD 3498.00, Standard Rate: Conference Only: USD 2899.00


Finally Drugging The "Undruggable" Proteome

With about 85% of the proteome currently undrugged, accessing these targets that are, at present, extremely difficult to drug, has prevented researchers from achieving desired clinical successes.

The 2nd Proteome- Targeted Drug Discovery Summit will unite large pharma and innovative biotech, as well as key opinion leaders in academia, to develop robust structural and biochemical tools to open up the full therapeutic opportunity held within the entire proteome. Identify and validate novel druggable sites and optimize structure-guided fragment-based drug design of small molecules with improved potency, selectivity, and physio-chemical properties.

Join the pioneering directors, team leaders and senior scientists from the biopharmaceutical industry and academia to enhance your existing structural, chemical and computational toolbox and explore how these innovative technologies can be uniquely employed to target the entire proteome and advance your small molecule drug discovery pipeline.

URLs:
Tickets: https://go.evvnt.com/587450-0?pid=1052
Brochure: https://go.evvnt.com/587450-2?pid=1052
 


Speaker Details


Speakers:
Anup Upadhyay, Principal Research Scientist I, AbbVie, Benjamin Ruprecht, Associate Principal Scientist of Chemical Biology, Merck, Christopher Browne, Senior Research Scientist, AstraZeneca, Christopher Dimitri, Investigator, GSK, Dave Wustrow, SVP of Discovery and Pre-Clinical Development, RAPT Therapeutics, Douglas Johnson, Senior Director of Chemical Biology and Proteomics, Biogen, Evris Gavathiotis, Professor of Biochemistry and Medicine, Albert Einstein College of Medicine, Grahame McKenzie, Chief Scientific Officer, Phoremost, Holly Soutter, Director of Biophysics and Biochemistry, Silicon Therapeutics, Jenny Viklund, Director of Protein Science and Drug Design, Sprint Bioscience, Kristin Riching, Senior Research Scientist, Promega, Mario Niepel, Associate Director, Ribon Therapeutics, Nathan Fuller, Director of Chemistry, Alkermes, Nick Shah, Head of In Vitro Pharmacology, DiCE Molecules, Nir London, Senior Scientist, The Weizmann Institute of Science, Thomas Smith, Senior Investigator, Novartis, William Pomerantz, Associate Professor of Chemistry, University of Minnesota

Event Categories
Keywords: conference , Health , medicine, science




Comments








Events Calendar

SunMonTueWedThuFriSat
31 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 1 2 3 4

Newsletters

VIP Life Time Subscription to our Newsletters!
$399.99
$299.99